Evidence map›Paper›PMID 29848990›Full record

ArticleMolecules (Basel, Switzerland)2018

Knowledge-Based Neuroendocrine Immunomodulation (NIM) Molecular Network Construction and Its Application.

Tongxing Wang, Lu Han, Xiaorui Zhang, Rongrong Wu, Xiaorui Cheng, Wenxia Zhou, Yongxiang Zhang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tongxing WangBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China. wangtongxing89@126.com.ORCID 0000-0002-4008-7230
Lu HanBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China. bmigroup2@163.com.
Xiaorui ZhangBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China. zhangx_r@126.com.
Rongrong WuBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China. wrr302@163.com.
Xiaorui ChengBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China. cxr916@163.com.
Wenxia ZhouBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China. zhouwx@bmi.ac.cn.
Yongxiang ZhangBeijing Institute of Pharmacology and Toxicology, Beijing 100850, China. zhangyx@bmi.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing evidence shows that the neuroendocrine immunomodulation (NIM) network plays an important role in maintaining and modulating body function and the homeostasis of the internal environment. The disequilibrium of NIM in the body is closely associated with many diseases. In the present study, we first collected a core dataset of NIM signaling molecules based on our knowledge and obtained 611 NIM signaling molecules. Then, we built a NIM molecular network based on the MetaCore database and analyzed the signaling transduction characteristics of the core network. We found that the endocrine system played a pivotal role in the bridge between the nervous and immune systems and the signaling transduction between the three systems was not homogeneous. Finally, employing the forest algorithm, we identified the molecular hub playing an important role in the pathogenesis of rheumatoid arthritis (RA) and Alzheimer's disease (AD), based on the NIM molecular network constructed by us. The results showed that

Indexed as

Gene Regulatory NetworksSignal TransductionAlzheimer DiseaseArthritis, RheumatoidGene Expression ProfilingHumansImmunomodulationNeuroendocrine CellsTranscriptomeAlzheimer’s diseasedisease networkdrug targetneuroendocrine immunomodulation networkpathogenesisrheumatoid arthritis

Identifiers

PMID29848990
PMCPMC6099962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.